Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGENUS INCAGEN · Entity 5774 | Director | August 05, 2026 | August 07, 2026 |
| TECOGEN INC.TGEN · Entity 6846 | Director | June 26, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGENUS INC
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.78 · Expires 2036-08-05 | Direct | 50,000 |
Reported balance
After 2026-08-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-05 · Grant · Acquired 50,000 · Balance 50,000 F1: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
TECOGEN INC.
Report date June 26, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.17 · Expires 2036-06-26 | Direct | 25,000 |
Reported balance
After 2026-06-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 25,000 · Balance 25,000 F1: Vests 25% per year |
Filing footnotes · ownership attribution and instrument terms
F1: Vests 25% per year
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 18:16 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0001193125-26-339968 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-08-05 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter. Read SEC document |
| June 26, 2026 Filed Jul 1, 2026 00:34 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $5.17 Strike: $5.17 | $129,250.00 |
DisclosureSEC source: 0001537435-26-000046 · wk-form4_1782866039.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-06-26 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:15 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 105,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001193125-26-187090 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2036-04-24 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 20:03 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $3.73 | $18,650.00 |
DisclosureSEC source: 0001827663-26-000004 · wk-form4_1776197000.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,416 Read SEC document |
| March 27, 2026 Filed Mar 27, 2026 20:24 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 10,000 | $2.54 | $25,400.00 |
DisclosureSEC source: 0001827663-26-000002 · wk-form4_1774643070.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,416 Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 15:02 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $8.35 Strike: $8.35 | $208,750.00 |
DisclosureSEC source: 0001537435-25-000117 · wk-form4_1753714943.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 25,000 shares Expires 2035-07-24 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 15,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0000950170-25-088504 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2035-05-28 F1 · derivative.exercise_date: Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 21:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,416.074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-000403 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,206.567 Underlying: Common Stock · 6,416.074 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.70 per Deferred Stock Unit acquired on January 2, 2025. The price of each Deferred Stock Unit acquired on January 2, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 12:38 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 3,172.98 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-112004 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,790.493 Underlying: Common Stock · 3,172.98 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $7.49 per Deferred Stock Unit acquired on October 1, 2024. The price of each Deferred Stock Unit acquired on October 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2024 Filed Jul 1, 2024 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 1,827.956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-079584 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,617.513 Underlying: Common Stock · 1,827.956 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $12.08 per Deferred Stock Unit acquired on July 1, 2024. The price of each Deferred Stock Unit acquired on July 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 06, 2024 Filed Jun 18, 2024 19:52 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Options (Right to Buy) · Derivative | 25,000 | $0.77 Strike: $0.77 | $19,250.00 |
DisclosureSEC source: 0001537435-24-000086 · wk-form4_1718740331.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 25,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
| April 01, 2024 Filed Apr 1, 2024 20:23 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 32,039.161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-039357 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,791.152 Underlying: Common Stock · 32,039.161 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $0.66 per Deferred Stock Unit acquired on April 1, 2024. The price of each Deferred Stock Unit acquired on April 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| February 05, 2024 Filed Apr 22, 2024 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 5,000 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0000950170-24-046420 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-02-05 F1 · derivative.exercise_date: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 11:06 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 25,671.141 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-001479 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,751.991 Underlying: Common Stock · 25,671.141 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $0.83 per Deferred Stock Unit acquired on January 2, 2024. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| November 15, 2023 Filed Feb 12, 2024 12:00 UTC | AGENUS INC AGEN · Entity 5774 | OtherCommon Stock | 5,000 | $0.75 | $3,750.00 |
DisclosureSEC source: 0000950170-24-013560 · ownership.xml · nonDerivative · entry 2 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,725 F1 · shares: Represents open market purchase of common stock for cash. Read SEC document |
| November 14, 2023 Filed Feb 12, 2024 12:00 UTC | AGENUS INC AGEN · Entity 5774 | OtherCommon Stock | 5,000 | $0.67 | $3,350.00 |
DisclosureSEC source: 0000950170-24-013560 · ownership.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,725 F1 · shares: Represents open market purchase of common stock for cash. Read SEC document |
| October 19, 2023 Filed Oct 20, 2023 22:14 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 5,000 | $0.92 | $4,575.00 |
DisclosureSEC source: 0001537435-23-000141 · wk-form4_1697840034.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,416 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:11 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 14,927.713 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-051969 · ownership.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,080.85 Underlying: Common Stock · 14,927.713 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 62.21 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:30 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 13,283.487 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-017125 · doc4.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,153.14 Underlying: Common Stock · 13,283.487 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 03, 2023 Filed Apr 3, 2023 19:59 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 9,869.6532 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-010208 · doc4.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,869.6532 Underlying: Common Stock · 9,869.6532 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.153 per Deferred Stock Unit acquired on April 3, 2023. The price of each Deferred Stock Unit acquired on April 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 08, 2023 Filed Jan 10, 2023 00:14 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0000899243-23-001364 · doc4.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-01-08 F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 16:20 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 7,239 | $2.59 | $18,749.01 |
DisclosureSEC source: 0000899243-23-000500 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,725 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $2.590 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 17:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 7,216 | $2.60 | $18,747.17 |
DisclosureSEC source: 0000899243-22-032915 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,486 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $2.598 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:51 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 10,138 | $1.85 | $18,755.30 |
DisclosureSEC source: 0000899243-22-025322 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,270 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $1.85 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. F3 · balance_after: The number of shares owned following the reported transaction includes 55,750 shares beneficially owned by the reporting person at the time she was appointed a director, which shares were reported on a Form 3 filed on October 13, 2020. The reporting person has continued to beneficially own such shares since October 13, 2020, but they were inadvertently omitted from Form 4 filings previously filed by the reporting person. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:35 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 6,811 | $2.75 | $18,750.68 |
DisclosureSEC source: 0000899243-22-013872 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,382 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $2.753 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 23:09 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0000899243-22-005238 · doc4.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-04 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 19:59 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 4,677 | $4.01 | $18,754.77 |
DisclosureSEC source: 0000899243-22-000851 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,571 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $4.009 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:18 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 3,257 | $5.76 | $18,760.32 |
DisclosureSEC source: 0000899243-21-039312 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,894 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $5.757 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 23:32 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 4,908 | $3.82 | $18,748.56 |
DisclosureSEC source: 0000899243-21-027354 · doc4.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,637 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $3.820 is the is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| June 15, 2021 Filed Jul 2, 2021 23:32 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0000899243-21-027354 · doc4.xml · derivative · entry 2 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F3 · derivative.exercise_date: Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:56 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 5,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-21-000017 · primary_doc.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,729 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $3.682 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:58 UTC | AGENUS INC AGEN · Entity 5774 | GrantCommon Stock | 3,637 | $3.78 | $13,747.86 |
DisclosureSEC source: 0001745285-21-000006 · primary_doc.xml · nonDerivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,637 F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock. F2 · price: $3.78 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 19:16 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 100,000 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0001745285-20-000048 · primary_doc.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The Stock Option vests in full on December 17, 2021 (provided Ms. Hirsch continues to serve on the board on such date). Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 14:20 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 100,000 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001745285-20-000037 · primary_doc.xml · derivative · entry 1 Hirsch Susan B · CIK 0001827663 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-10-08 F1 · derivative.exercise_date: Stock Option awarded in connection with Ms. Hirsch's appointment to the Board of Directors in accordance with the Agenus Inc. 2019 Equity Incentive Plan and non-employee director compensation program. Stock option vests in three equal annual installments on each of October 8, 2021, 2022 and 2023 (provided Ms. Hirsch maintains a service relationship with the company through each such vesting date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.